The tyre maker posted strong fourth-quarter earnings driven by robust demand and announced a phased capacity expansion amid rising domestic and export opportunities
Q4FY26 company results: Firms including Bayer CropScience, AIA Engineering, Aequs, Astra Microwave Products, and Balaji Telefilms are also to release their January-March earnings today
The rise in net profit came at a time when the Gurugram-headquartered company's revenue from operations rose 17 per cent to ₹700.51 crore in Q4 FY26, up from ₹598.64 crore in Q4 FY25
The consolidated net profit stood at ₹1,181 crore in the quarter ended March 2025, Suzlon Energy said in a statement
The total income fell to ₹4,618.59 crore during the fourth quarter of 2025-26 from ₹4,700.86 crore in the corresponding period of the preceding year, according to a regulatory filing
Q4FY26 company results: Firms including Amara Raja Energy & Mobility, Awfis Space Solutions, Campus Activewear, and Chemplast Sanmar are also to release their January-March earnings today
The insurance behemoth was followed by the country's biggest lender State Bank of India (SBI), and the second-biggest lender HDFC Bank with profit of ₹19,684 crore and ₹19,221 crore
Reliance Infrastructure's revenue from operations dipped 2.59 per cent in the March quarter, while its board approved plans to raise up to Rs 3,000 crore
Q4FY26 company results: Firms including Rainbow Children's Medicare, Anupam Rasayan India, Dollar Industries, Polyplex, and Precision Wires are also to release their January-March earnings today
Info Edge posted double-digit profit growth in Q4, powered by strong performance in its recruitment solutions business led by Naukri.com
The company had posted a net profit of Rs 498 crore in the corresponding period of the preceding fiscal, Torrent Pharmaceuticals said in a statement
The Aditya Birla Group company reported a sharp fall in quarterly profit as charges linked to fire disruptions at Novelis offset gains from higher metal prices
Innovative medicines business crosses $1 billion milestone as company expands specialty pipeline and bets on Organon acquisition
Blackstone-backed Kolte-Patil Developers reports Q4 FY26 loss as lower revenue recognition offsets strong collections and steady housing sales
Torrent Pharma's Q4 profit dropped 22% as JB Pharma integration costs pushed up expenses, despite strong growth in semaglutide-led revenues
For FY 2025-26, consolidated PAT stood at Rs 358 crore, while consolidated revenue surged 22.3 per cent year-on-year to Rs 6,185 crore, the company said
Generali Central Life Insurance reported widening of loss to Rs 178 crore for FY26 driven by strategic investments towards brand transition and market expansion.
India's largest drugmaker reported stronger-than-expected quarterly profit as growth in specialty medicines offset weakness in US sales
Total income also more than doubled to ₹4,143.5 crore during the January-March period of 2025-26 fiscal from ₹1,589.3 crore in the corresponding period of the preceding year
PIL's revenue from operations was up 14 per cent to ₹1,252.6 crore in the March quarter of FY'26. It was ₹1,098.07 crore in the corresponding period a year ago